This article was first published in Norwegian on our school collaboration website. Read it here. Through the collaboration between Oslo Cancer Cluster and Ullern Upper Secondary School, former Ullern-student Eivind Lysheim has found his way in life – both academically and professionally. “I am very thankful for this,” said Eivind. “I want to thank you […]
Norwegian government to double the number of clinical studies.
Dehns acquires Norwegian Intellectual Property consultancy Leogriff.
Ultimovacs has announced a new clinical study targeted at patients with ovarian cancer.
CONNECT is a completely new public-private collaboration in cancer precision medicine.
Read a selection of our news from 2020.